Diethylcarbamazine-Induced Reversal of Early Lymphatic Dysfunction in a Patient with Bancroftian Filariasis: Assessment with Use of Lymphoscintigraphy
Identifieur interne : 00BE83 ( Main/Exploration ); précédent : 00BE82; suivant : 00BE84Diethylcarbamazine-Induced Reversal of Early Lymphatic Dysfunction in a Patient with Bancroftian Filariasis: Assessment with Use of Lymphoscintigraphy
Auteurs : Thomas A. Moore [Gabon] ; James C. Reynolds [Gabon] ; Richard T. Kenney [Gabon] ; William Johnston [Gabon] ; Thomas B. Nutman [Gabon]Source :
- Clinical Infectious Diseases [ 1058-4838 ] ; 1996-11.
Descripteurs français
- KwdFr :
- Adulte, Animaux, Anticorps antihelminthe (analyse), Diéthylcarbamazine (usage thérapeutique), Filariose lymphatique (imagerie diagnostique), Filariose lymphatique (immunologie), Filariose lymphatique (physiopathologie), Filariose lymphatique (traitement médicamenteux), Humains, Imagerie par résonance magnétique, Scintigraphie, Wuchereria bancrofti (immunologie), Wuchereria bancrofti (isolement et purification).
- MESH :
- analyse : Anticorps antihelminthe.
- imagerie diagnostique : Filariose lymphatique.
- immunologie : Filariose lymphatique, Wuchereria bancrofti.
- isolement et purification : Wuchereria bancrofti.
- physiopathologie : Filariose lymphatique.
- traitement médicamenteux : Filariose lymphatique.
- usage thérapeutique : Diéthylcarbamazine.
- Adulte, Animaux, Humains, Imagerie par résonance magnétique, Scintigraphie.
English descriptors
- KwdEn :
- Adult, Animals, Antibodies, Helminth (analysis), Diethylcarbamazine (therapeutic use), Elephantiasis, Filarial (diagnostic imaging), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (immunology), Elephantiasis, Filarial (physiopathology), Humans, Magnetic Resonance Imaging, Radionuclide Imaging, Wuchereria bancrofti (immunology), Wuchereria bancrofti (isolation & purification).
- MESH :
- chemical , analysis : Antibodies, Helminth.
- chemical , therapeutic use : Diethylcarbamazine.
- diagnostic imaging : Elephantiasis, Filarial.
- drug therapy : Elephantiasis, Filarial.
- immunology : Elephantiasis, Filarial, Wuchereria bancrofti.
- isolation & purification : Wuchereria bancrofti.
- physiopathology : Elephantiasis, Filarial.
- Adult, Animals, Humans, Magnetic Resonance Imaging, Radionuclide Imaging.
Abstract
Exposure of expatriates to the infective larvae of Wuchereria bancrofti can result in the early development of signs of lymphatic obstruction. The findings on the clinical presentation of expatriates are distinct from the chronic pathological findings seen among the native population and are similar to the findings in experimentally infected persons. We report the case of a Peace Corps volunteer who developed acute lymphatic dysfunction within 3 months of arriving in an area that was endemic for filariasis. The diagnosis was established clinically and by demonstrating the presence of antibodies to recombinant proteins specific for patients with lymphatic filariasis. Lymphatic flow was markedly abnormal when assessed with use of 99mTc-lymphoscintigraphy. Treatment with diethylcarbamazine reversed both the physical and lymphoscintigraphic abnormalities.
Url:
DOI: 10.1093/clinids/23.5.1007
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000640
- to stream Istex, to step Curation: 000640
- to stream Istex, to step Checkpoint: 004287
- to stream Main, to step Merge: 00C737
- to stream PubMed, to step Corpus: 005107
- to stream PubMed, to step Curation: 005107
- to stream PubMed, to step Checkpoint: 005107
- to stream Ncbi, to step Merge: 00B873
- to stream Ncbi, to step Curation: 00B873
- to stream Ncbi, to step Checkpoint: 00B873
- to stream Main, to step Merge: 00C573
- to stream Main, to step Curation: 00BE83
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Diethylcarbamazine-Induced Reversal of Early Lymphatic Dysfunction in a Patient with Bancroftian Filariasis: Assessment with Use of Lymphoscintigraphy</title><author><name sortKey="Moore, Thomas A" sort="Moore, Thomas A" uniqKey="Moore T" first="Thomas A." last="Moore">Thomas A. Moore</name></author><author><name sortKey="Reynolds, James C" sort="Reynolds, James C" uniqKey="Reynolds J" first="James C." last="Reynolds">James C. Reynolds</name></author><author><name sortKey="Kenney, Richard T" sort="Kenney, Richard T" uniqKey="Kenney R" first="Richard T." last="Kenney">Richard T. Kenney</name></author><author><name sortKey="Johnston, William" sort="Johnston, William" uniqKey="Johnston W" first="William" last="Johnston">William Johnston</name></author><author><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B." last="Nutman">Thomas B. Nutman</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:0E0E936AE515A19C5CDDEA18982C2FAFE924EE2B</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1093/clinids/23.5.1007</idno><idno type="url">https://api.istex.fr/document/0E0E936AE515A19C5CDDEA18982C2FAFE924EE2B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000640</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000640</idno><idno type="wicri:Area/Istex/Curation">000640</idno><idno type="wicri:Area/Istex/Checkpoint">004287</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">004287</idno><idno type="wicri:doubleKey">1058-4838:1996:Moore T:diethylcarbamazine:induced:reversal</idno><idno type="wicri:Area/Main/Merge">00C737</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:8922794</idno><idno type="wicri:Area/PubMed/Corpus">005107</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005107</idno><idno type="wicri:Area/PubMed/Curation">005107</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005107</idno><idno type="wicri:Area/PubMed/Checkpoint">005107</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005107</idno><idno type="wicri:Area/Ncbi/Merge">00B873</idno><idno type="wicri:Area/Ncbi/Curation">00B873</idno><idno type="wicri:Area/Ncbi/Checkpoint">00B873</idno><idno type="wicri:doubleKey">1058-4838:1996:Moore T:diethylcarbamazine:induced:reversal</idno><idno type="wicri:Area/Main/Merge">00C573</idno><idno type="wicri:Area/Main/Curation">00BE83</idno><idno type="wicri:Area/Main/Exploration">00BE83</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Diethylcarbamazine-Induced Reversal of Early Lymphatic Dysfunction in a Patient with Bancroftian Filariasis: Assessment with Use of Lymphoscintigraphy</title><author><name sortKey="Moore, Thomas A" sort="Moore, Thomas A" uniqKey="Moore T" first="Thomas A." last="Moore">Thomas A. Moore</name><affiliation wicri:level="1"><country xml:lang="fr">Gabon</country><wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, and the Department of Nuclear Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, Libreville</wicri:regionArea><wicri:noRegion>Libreville</wicri:noRegion></affiliation></author><author><name sortKey="Reynolds, James C" sort="Reynolds, James C" uniqKey="Reynolds J" first="James C." last="Reynolds">James C. Reynolds</name><affiliation wicri:level="1"><country xml:lang="fr">Gabon</country><wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, and the Department of Nuclear Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, Libreville</wicri:regionArea><wicri:noRegion>Libreville</wicri:noRegion></affiliation></author><author><name sortKey="Kenney, Richard T" sort="Kenney, Richard T" uniqKey="Kenney R" first="Richard T." last="Kenney">Richard T. Kenney</name><affiliation wicri:level="1"><country xml:lang="fr">Gabon</country><wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, and the Department of Nuclear Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, Libreville</wicri:regionArea><wicri:noRegion>Libreville</wicri:noRegion></affiliation></author><author><name sortKey="Johnston, William" sort="Johnston, William" uniqKey="Johnston W" first="William" last="Johnston">William Johnston</name><affiliation wicri:level="1"><country xml:lang="fr">Gabon</country><wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, and the Department of Nuclear Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, Libreville</wicri:regionArea><wicri:noRegion>Libreville</wicri:noRegion></affiliation></author><author><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B." last="Nutman">Thomas B. Nutman</name><affiliation wicri:level="1"><country xml:lang="fr">Gabon</country><wicri:regionArea>Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, and the Department of Nuclear Medicine, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, Libreville</wicri:regionArea><wicri:noRegion>Libreville</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Infectious Diseases</title><title level="j" type="abbrev">Clinical Infectious Diseases</title><idno type="ISSN">1058-4838</idno><idno type="eISSN">1537-6591</idno><imprint><publisher>The University of Chicago Press</publisher><date type="published" when="1996-11">1996-11</date><biblScope unit="volume">23</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="1007">1007</biblScope><biblScope unit="page" to="1011">1011</biblScope></imprint><idno type="ISSN">1058-4838</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1058-4838</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Animals</term><term>Antibodies, Helminth (analysis)</term><term>Diethylcarbamazine (therapeutic use)</term><term>Elephantiasis, Filarial (diagnostic imaging)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (immunology)</term><term>Elephantiasis, Filarial (physiopathology)</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Radionuclide Imaging</term><term>Wuchereria bancrofti (immunology)</term><term>Wuchereria bancrofti (isolation & purification)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Animaux</term><term>Anticorps antihelminthe (analyse)</term><term>Diéthylcarbamazine (usage thérapeutique)</term><term>Filariose lymphatique (imagerie diagnostique)</term><term>Filariose lymphatique (immunologie)</term><term>Filariose lymphatique (physiopathologie)</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Humains</term><term>Imagerie par résonance magnétique</term><term>Scintigraphie</term><term>Wuchereria bancrofti (immunologie)</term><term>Wuchereria bancrofti (isolement et purification)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Helminth</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Diethylcarbamazine</term></keywords><keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Anticorps antihelminthe</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Diéthylcarbamazine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Animals</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Radionuclide Imaging</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Animaux</term><term>Humains</term><term>Imagerie par résonance magnétique</term><term>Scintigraphie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">Exposure of expatriates to the infective larvae of Wuchereria bancrofti can result in the early development of signs of lymphatic obstruction. The findings on the clinical presentation of expatriates are distinct from the chronic pathological findings seen among the native population and are similar to the findings in experimentally infected persons. We report the case of a Peace Corps volunteer who developed acute lymphatic dysfunction within 3 months of arriving in an area that was endemic for filariasis. The diagnosis was established clinically and by demonstrating the presence of antibodies to recombinant proteins specific for patients with lymphatic filariasis. Lymphatic flow was markedly abnormal when assessed with use of 99mTc-lymphoscintigraphy. Treatment with diethylcarbamazine reversed both the physical and lymphoscintigraphic abnormalities.</div></front></TEI><affiliations><list><country><li>Gabon</li></country></list><tree><country name="Gabon"><noRegion><name sortKey="Moore, Thomas A" sort="Moore, Thomas A" uniqKey="Moore T" first="Thomas A." last="Moore">Thomas A. Moore</name></noRegion><name sortKey="Johnston, William" sort="Johnston, William" uniqKey="Johnston W" first="William" last="Johnston">William Johnston</name><name sortKey="Kenney, Richard T" sort="Kenney, Richard T" uniqKey="Kenney R" first="Richard T." last="Kenney">Richard T. Kenney</name><name sortKey="Nutman, Thomas B" sort="Nutman, Thomas B" uniqKey="Nutman T" first="Thomas B." last="Nutman">Thomas B. Nutman</name><name sortKey="Reynolds, James C" sort="Reynolds, James C" uniqKey="Reynolds J" first="James C." last="Reynolds">James C. Reynolds</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00BE83 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00BE83 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:0E0E936AE515A19C5CDDEA18982C2FAFE924EE2B
|texte= Diethylcarbamazine-Induced Reversal of Early Lymphatic Dysfunction in a Patient with Bancroftian Filariasis: Assessment with Use of Lymphoscintigraphy
}}
| This area was generated with Dilib version V0.6.31. |  |